RNS Number : 9507D Chesnara PLC 07 April 2025 CHESNARA plc ("Chesnara" or "the Company") LEI Number: 213800VFRMBRTSZ3SJ06 7 April 2025 NOTIFICATION OF PDMR & PCA DEALING Chesnara plc (CSN.L) (the 'Company') announces that it has been informed that Mr Gavin Hughes, considered a PDMR in his capacity as Group Chief Risk Officer and Chief Actuary, transferred 3,275 ordinary shares of 5 pence each in the Company, to Mrs Emma Hughes, a person closely associated ("PCA") with Mr Hughes on 31 March 2025. The above notification is made in accordance with the requirements of the EU Market Abuse Regulation (as retained in UK law). For further information, please contact: Investor Enquiries Sam Perowne Head of Strategic Development & Investor Relations Chesnara plc E - sam.perowne@chesnara.co.uk Media Enquiries Roddy Watt Director, Capital Markets FWD T - 020 7280 0651 / 07714 770 493 E - roddy.watt@fwdconsulting.co.uk Notes to Editors Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange.  It administers just under one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands and as Movestic in Sweden. Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in the UK, Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios. Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 20 years in succession. Further details are available on the Company's website (www.chesnara.co.uk). This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END DSHUPUMUCUPAGGM